<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2020-10-07" version="213">
<accession>P08637</accession>
<accession>A2N6W9</accession>
<accession>Q53FJ0</accession>
<accession>Q53FL6</accession>
<accession>Q5EBR4</accession>
<accession>Q65ZM6</accession>
<accession>Q6PIJ0</accession>
<name>FCG3A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Low affinity immunoglobulin gamma Fc region receptor III-A</fullName>
</recommendedName>
<alternativeName>
<fullName>CD16a antigen</fullName>
</alternativeName>
<alternativeName>
<fullName>Fc-gamma RIII-alpha</fullName>
<shortName>Fc-gamma RIII</shortName>
<shortName>Fc-gamma RIIIa</shortName>
<shortName>FcRIII</shortName>
<shortName>FcRIIIa</shortName>
</alternativeName>
<alternativeName>
<fullName>FcR-10</fullName>
</alternativeName>
<alternativeName>
<fullName>IgG Fc receptor III-2</fullName>
</alternativeName>
<cdAntigenName>CD16a</cdAntigenName>
</protein>
<gene>
<name type="primary">FCGR3A</name>
<name type="synonym">CD16A</name>
<name type="synonym">FCG3</name>
<name type="synonym">FCGR3</name>
<name type="synonym">IGFR3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="J. Exp. Med." volume="170" first="481" last="497">
<title>Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.</title>
<authorList>
<person name="Ravetch J.V."/>
<person name="Perussia B."/>
</authorList>
<dbReference type="PubMed" id="2526846"/>
<dbReference type="DOI" id="10.1084/jem.170.2.481"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="J. Immunol." volume="177" first="3848" last="3856">
<title>IgG Fc receptor III homologues in nonhuman primate species: genetic characterization and ligand interactions.</title>
<authorList>
<person name="Rogers K.A."/>
<person name="Scinicariello F."/>
<person name="Attanasio R."/>
</authorList>
<dbReference type="PubMed" id="16951347"/>
<dbReference type="DOI" id="10.4049/jimmunol.177.6.3848"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Suzuki Y."/>
<person name="Sugano S."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT VAL-176</scope>
<source>
<tissue>Synovium</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT VAL-176</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="1350" last="1361">
<title>The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions.</title>
<authorList>
<person name="Gessner J.E."/>
<person name="Grussenmeyer T."/>
<person name="Kolanus W."/>
<person name="Schmidt R.E."/>
</authorList>
<dbReference type="PubMed" id="7836402"/>
<dbReference type="DOI" id="10.1074/jbc.270.3.1350"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-39</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1994" name="Kidney Int." volume="46" first="1627" last="1634">
<title>Human glomerular mesangial cells express CD16 and may be stimulated via this receptor.</title>
<authorList>
<person name="Morcos M."/>
<person name="Hansch G.M."/>
<person name="Schonermark M."/>
<person name="Ellwanger S."/>
<person name="Harle M."/>
<person name="Heckl-Ostreicher B."/>
</authorList>
<dbReference type="PubMed" id="7700021"/>
<dbReference type="DOI" id="10.1038/ki.1994.462"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 22-254</scope>
<scope>VARIANT VAL-176</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="5079" last="5083">
<title>A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms.</title>
<authorList>
<person name="Scallon B.J."/>
<person name="Scigliano E."/>
<person name="Freedman V.H."/>
<person name="Miedel M.C."/>
<person name="Pan Y.C."/>
<person name="Unkeless J.C."/>
<person name="Kochan J.P."/>
</authorList>
<dbReference type="PubMed" id="2525780"/>
<dbReference type="DOI" id="10.1073/pnas.86.13.5079"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 31-254</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="Genes Cells" volume="16" first="1071" last="1080">
<title>Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.</title>
<authorList>
<person name="Mizushima T."/>
<person name="Yagi H."/>
<person name="Takemoto E."/>
<person name="Shibata-Koyama M."/>
<person name="Isoda Y."/>
<person name="Iida S."/>
<person name="Masuda K."/>
<person name="Satoh M."/>
<person name="Kato K."/>
</authorList>
<dbReference type="PubMed" id="22023369"/>
<dbReference type="DOI" id="10.1111/j.1365-2443.2011.01552.x"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 21-193 IN COMPLEX WITH IGHG1</scope>
<scope>FUNCTION</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-63 AND ASN-180</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="12669" last="12674">
<title>Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.</title>
<authorList>
<person name="Ferrara C."/>
<person name="Grau S."/>
<person name="Jager C."/>
<person name="Sondermann P."/>
<person name="Brunker P."/>
<person name="Waldhauer I."/>
<person name="Hennig M."/>
<person name="Ruf A."/>
<person name="Rufer A.C."/>
<person name="Stihle M."/>
<person name="Umana P."/>
<person name="Benz J."/>
</authorList>
<dbReference type="PubMed" id="21768335"/>
<dbReference type="DOI" id="10.1073/pnas.1108455108"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 19-208 IN COMPLEX WITH IGHG1</scope>
<scope>FUNCTION</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-63 AND ASN-180</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="J. Immunol." volume="156" first="2948" last="2955">
<title>A triallelic Fc gamma receptor type IIIA polymorphism influences the binding of human IgG by NK cell Fc gamma RIIIa.</title>
<authorList>
<person name="de Haas M."/>
<person name="Koene H.R."/>
<person name="Kleijer M."/>
<person name="de Vries E."/>
<person name="Simsek S."/>
<person name="van Tol M.J.D."/>
<person name="Roos D."/>
<person name="von dem Borne A.E.G.K."/>
</authorList>
<dbReference type="PubMed" id="8609432"/>
</citation>
<scope>INVOLVEMENT IN IMD20</scope>
<scope>VARIANT IMD20 HIS-66</scope>
<scope>VARIANT ARG-66</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Blood" volume="90" first="1109" last="1114">
<title>Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype.</title>
<authorList>
<person name="Koene H.R."/>
<person name="Kleijer M."/>
<person name="Algra J."/>
<person name="Roos D."/>
<person name="von dem Borne A.E.G.K."/>
<person name="de Haas M."/>
</authorList>
<dbReference type="PubMed" id="9242542"/>
</citation>
<scope>VARIANT VAL-176</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="J. Clin. Invest." volume="100" first="1059" last="1070">
<title>A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.</title>
<authorList>
<person name="Wu J."/>
<person name="Edberg J.C."/>
<person name="Redecha P.B."/>
<person name="Bansal V."/>
<person name="Guyre P.M."/>
<person name="Coleman K."/>
<person name="Salmon J.E."/>
<person name="Kimberly R.P."/>
</authorList>
<dbReference type="PubMed" id="9276722"/>
<dbReference type="DOI" id="10.1172/jci119616"/>
</citation>
<scope>VARIANT VAL-176</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="Blood" volume="88" first="3022" last="3027">
<title>Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections.</title>
<authorList>
<person name="de Vries E."/>
<person name="Koene H.R."/>
<person name="Vossen J.M."/>
<person name="Gratama J.W."/>
<person name="von dem Borne A.E."/>
<person name="Waaijer J.L."/>
<person name="Haraldsson A."/>
<person name="de Haas M."/>
<person name="van Tol M.J."/>
</authorList>
<dbReference type="PubMed" id="8874200"/>
</citation>
<scope>INVOLVEMENT IN IMD20</scope>
<scope>VARIANT IMD20 HIS-66</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1996" name="Clin. Exp. Immunol." volume="103" first="408" last="413">
<title>Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II).</title>
<authorList>
<person name="Jawahar S."/>
<person name="Moody C."/>
<person name="Chan M."/>
<person name="Finberg R."/>
<person name="Geha R."/>
<person name="Chatila T."/>
</authorList>
<dbReference type="PubMed" id="8608639"/>
<dbReference type="DOI" id="10.1111/j.1365-2249.1996.tb08295.x"/>
</citation>
<scope>VARIANT IMD20 HIS-66</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="J. Clin. Invest." volume="122" first="3769" last="3780">
<title>Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.</title>
<authorList>
<person name="Grier J.T."/>
<person name="Forbes L.R."/>
<person name="Monaco-Shawver L."/>
<person name="Oshinsky J."/>
<person name="Atkinson T.P."/>
<person name="Moody C."/>
<person name="Pandey R."/>
<person name="Campbell K.S."/>
<person name="Orange J.S."/>
</authorList>
<dbReference type="PubMed" id="23006327"/>
<dbReference type="DOI" id="10.1172/jci64837"/>
</citation>
<scope>VARIANT IMD20 HIS-66</scope>
</reference>
<comment type="function">
<text evidence="7 8">Receptor for the Fc region of IgG. Binds complexed or aggregated IgG and also monomeric IgG. Mediates antibody-dependent cellular cytotoxicity (ADCC) and other antibody-dependent responses, such as phagocytosis.</text>
</comment>
<comment type="subunit">
<text evidence="4">Exists as a heterooligomeric receptor complex with Fc epsilon receptor I gamma subunit and / or the CD3 zeta subunit. Interacts with INPP5D/SHIP1 (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cell membrane</location>
<topology evidence="17">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
<text>Exists also as a soluble receptor.</text>
</comment>
<comment type="tissue specificity">
<text>Expressed on natural killer cells, macrophages, subpopulation of T-cells, immature thymocytes and placental trophoblasts.</text>
</comment>
<comment type="PTM">
<text evidence="7 8">Glycosylated. Contains high mannose- and complex-type oligosaccharides. Glycosylation at Asn-180 is mandatory for high affinity binding to the Fc and for discrimination between fucosylated and afucosylated IgG glycoforms.</text>
</comment>
<comment type="PTM">
<text>The soluble form is produced by a proteolytic cleavage.</text>
</comment>
<comment type="disease" evidence="9 11 12 13">
<disease id="DI-04050">
<name>Immunodeficiency 20</name>
<acronym>IMD20</acronym>
<description>A rare autosomal recessive primary immunodeficiency characterized by functional deficiency of NK cells. Affected individuals typically present with severe herpes viral infections, particularly Epstein Barr virus (EBV), and human papillomavirus (HPV).</description>
<dbReference type="MIM" id="615707"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Encoded by one of two nearly indentical genes: FCGR3A (Shown here) and FCGR3B which are expressed in a tissue-specific manner. The Phe-203 in III-A determines the transmembrane domains whereas the 'Ser-203' in III-B determines the GPI-anchoring.</text>
</comment>
<comment type="sequence caution" evidence="17">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD96988" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="17">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD97015" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="FCGR3Abase">
<link uri="http://structure.bmc.lu.se/idbase/FCGR3Abase/"/>
<text>FCGR3A mutation db</text>
</comment>
<dbReference type="EMBL" id="X52645">
<property type="protein sequence ID" value="CAA36870.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223268">
<property type="protein sequence ID" value="BAD96988.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223295">
<property type="protein sequence ID" value="BAD97015.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL590385">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017865">
<property type="protein sequence ID" value="AAH17865.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC033678">
<property type="protein sequence ID" value="AAH33678.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z46222">
<property type="protein sequence ID" value="CAA86295.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S76824">
<property type="protein sequence ID" value="AAB33925.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M24853">
<property type="protein sequence ID" value="AAA53506.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1232.2"/>
<dbReference type="CCDS" id="CCDS44266.1"/>
<dbReference type="PIR" id="JL0107">
<property type="entry name" value="JL0107"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000560.6">
<property type="nucleotide sequence ID" value="NM_000569.7"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121064.2">
<property type="nucleotide sequence ID" value="NM_001127592.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121065.1">
<property type="nucleotide sequence ID" value="NM_001127593.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121067.1">
<property type="nucleotide sequence ID" value="NM_001127595.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121068.1">
<property type="nucleotide sequence ID" value="NM_001127596.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001316049.1">
<property type="nucleotide sequence ID" value="NM_001329120.1"/>
</dbReference>
<dbReference type="PDB" id="3AY4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="C=21-193"/>
</dbReference>
<dbReference type="PDB" id="3SGJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="C=19-208"/>
</dbReference>
<dbReference type="PDB" id="3SGK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C=19-208"/>
</dbReference>
<dbReference type="PDB" id="3WN5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="C/F=18-208"/>
</dbReference>
<dbReference type="PDB" id="5BW7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C=21-193"/>
</dbReference>
<dbReference type="PDB" id="5D6D">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.13"/>
<property type="chains" value="C=14-205"/>
</dbReference>
<dbReference type="PDB" id="5ML9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=19-193"/>
</dbReference>
<dbReference type="PDB" id="5MN2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=19-193"/>
</dbReference>
<dbReference type="PDB" id="5VU0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="C=22-192"/>
</dbReference>
<dbReference type="PDB" id="5XJE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C=21-193"/>
</dbReference>
<dbReference type="PDB" id="5XJF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="C=21-193"/>
</dbReference>
<dbReference type="PDB" id="5YC5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="C=19-193"/>
</dbReference>
<dbReference type="PDBsum" id="3AY4"/>
<dbReference type="PDBsum" id="3SGJ"/>
<dbReference type="PDBsum" id="3SGK"/>
<dbReference type="PDBsum" id="3WN5"/>
<dbReference type="PDBsum" id="5BW7"/>
<dbReference type="PDBsum" id="5D6D"/>
<dbReference type="PDBsum" id="5ML9"/>
<dbReference type="PDBsum" id="5MN2"/>
<dbReference type="PDBsum" id="5VU0"/>
<dbReference type="PDBsum" id="5XJE"/>
<dbReference type="PDBsum" id="5XJF"/>
<dbReference type="PDBsum" id="5YC5"/>
<dbReference type="SMR" id="P08637"/>
<dbReference type="BioGRID" id="108508">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="IntAct" id="P08637">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000356946"/>
<dbReference type="ChEMBL" id="CHEMBL3856162"/>
<dbReference type="DrugBank" id="DB00054">
<property type="generic name" value="Abciximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00092">
<property type="generic name" value="Alefacept"/>
</dbReference>
<dbReference type="DrugBank" id="DB00087">
<property type="generic name" value="Alemtuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00074">
<property type="generic name" value="Basiliximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB12023">
<property type="generic name" value="Benralizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB06607">
<property type="generic name" value="Catumaxomab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00002">
<property type="generic name" value="Cetuximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00111">
<property type="generic name" value="Daclizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00095">
<property type="generic name" value="Efalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00005">
<property type="generic name" value="Etanercept"/>
</dbReference>
<dbReference type="DrugBank" id="DB00056">
<property type="generic name" value="Gemtuzumab ozogamicin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00028">
<property type="generic name" value="Human immunoglobulin G"/>
</dbReference>
<dbReference type="DrugBank" id="DB00078">
<property type="generic name" value="Ibritumomab tiuxetan"/>
</dbReference>
<dbReference type="DrugBank" id="DB00075">
<property type="generic name" value="Muromonab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00108">
<property type="generic name" value="Natalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00110">
<property type="generic name" value="Palivizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB11767">
<property type="generic name" value="Sarilumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00081">
<property type="generic name" value="Tositumomab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="3017"/>
<dbReference type="GlyGen" id="P08637">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P08637"/>
<dbReference type="PhosphoSitePlus" id="P08637"/>
<dbReference type="BioMuta" id="FCGR3A"/>
<dbReference type="DMDM" id="119876"/>
<dbReference type="jPOST" id="P08637"/>
<dbReference type="MassIVE" id="P08637"/>
<dbReference type="PaxDb" id="P08637"/>
<dbReference type="PeptideAtlas" id="P08637"/>
<dbReference type="PRIDE" id="P08637"/>
<dbReference type="ProteomicsDB" id="52146"/>
<dbReference type="TopDownProteomics" id="P08637"/>
<dbReference type="ABCD" id="P08637">
<property type="antibodies" value="2 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="20512">
<property type="antibodies" value="2208 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2214"/>
<dbReference type="Ensembl" id="ENST00000367967">
<property type="protein sequence ID" value="ENSP00000356944"/>
<property type="gene ID" value="ENSG00000203747"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000436743">
<property type="protein sequence ID" value="ENSP00000416607"/>
<property type="gene ID" value="ENSG00000203747"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000443193">
<property type="protein sequence ID" value="ENSP00000392047"/>
<property type="gene ID" value="ENSG00000203747"/>
</dbReference>
<dbReference type="GeneID" id="2214"/>
<dbReference type="KEGG" id="hsa:2214"/>
<dbReference type="UCSC" id="uc001gat.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2214"/>
<dbReference type="DisGeNET" id="2214"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000203747.9"/>
<dbReference type="GeneCards" id="FCGR3A"/>
<dbReference type="HGNC" id="HGNC:3619">
<property type="gene designation" value="FCGR3A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000203747">
<property type="expression patterns" value="Tissue enhanced (blood, lymphoid tissue)"/>
</dbReference>
<dbReference type="MalaCards" id="FCGR3A"/>
<dbReference type="MIM" id="146740">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615707">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P08637"/>
<dbReference type="OpenTargets" id="ENSG00000203747"/>
<dbReference type="Orphanet" id="437552">
<property type="disease" value="Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28065"/>
<dbReference type="eggNOG" id="ENOG502RU1M">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214398"/>
<dbReference type="HOGENOM" id="CLU_023383_1_0_1"/>
<dbReference type="InParanoid" id="P08637"/>
<dbReference type="KO" id="K06463"/>
<dbReference type="OrthoDB" id="866496at2759"/>
<dbReference type="PhylomeDB" id="P08637"/>
<dbReference type="PathwayCommons" id="P08637"/>
<dbReference type="Reactome" id="R-HSA-198933">
<property type="pathway name" value="Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029481">
<property type="pathway name" value="FCGR activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029482">
<property type="pathway name" value="Regulation of actin dynamics for phagocytic cup formation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2029485">
<property type="pathway name" value="Role of phospholipids in phagocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664323">
<property type="pathway name" value="FCGR3A-mediated IL10 synthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9664422">
<property type="pathway name" value="FCGR3A-mediated phagocytosis"/>
</dbReference>
<dbReference type="SIGNOR" id="P08637"/>
<dbReference type="BioGRID-ORCS" id="2214">
<property type="hits" value="4 hits in 847 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="FCGR3A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P08637"/>
<dbReference type="GeneWiki" id="FCGR3A"/>
<dbReference type="GenomeRNAi" id="2214"/>
<dbReference type="Pharos" id="P08637">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P08637"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P08637">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000203747">
<property type="expression patterns" value="Expressed in granulocyte and 114 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P08637">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P08637">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019864">
<property type="term" value="F:IgG binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0038096">
<property type="term" value="P:Fc-gamma receptor signaling pathway involved in phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0050776">
<property type="term" value="P:regulation of immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0390">IgG-binding protein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="5">
<location>
<begin position="1"/>
<end position="16"/>
</location>
</feature>
<feature type="chain" description="Low affinity immunoglobulin gamma Fc region receptor III-A" id="PRO_0000015150">
<location>
<begin position="17"/>
<end position="254"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="5">
<location>
<begin position="17"/>
<end position="208"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="5">
<location>
<begin position="209"/>
<end position="229"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="5">
<location>
<begin position="230"/>
<end position="254"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="24"/>
<end position="105"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="107"/>
<end position="189"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="56"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8">
<location>
<position position="63"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="92"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8">
<location>
<position position="180"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="187"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 7 8">
<location>
<begin position="47"/>
<end position="89"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 7 8">
<location>
<begin position="128"/>
<end position="172"/>
</location>
</feature>
<feature type="sequence variant" description="In IMD20; dbSNP:rs10127939." id="VAR_008800" evidence="9 11 12 13">
<original>L</original>
<variation>H</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10127939." id="VAR_008799" evidence="12">
<original>L</original>
<variation>R</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs443082." id="VAR_058398">
<original>G</original>
<variation>D</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs396716." id="VAR_058399">
<original>Y</original>
<variation>H</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="Shows a higher binding capacity of IgG1, IgG3 and IgG4; dbSNP:rs396991." id="VAR_003960" evidence="6 10 14 15 16">
<original>F</original>
<variation>V</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1042206." id="VAR_058400">
<original>F</original>
<variation>S</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAD96988/BAD97015." ref="3" evidence="17">
<original>I</original>
<variation>V</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAH33678." ref="5" evidence="17">
<original>A</original>
<variation>S</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="28"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="35"/>
<end position="38"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="43"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="51"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="60"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="71"/>
<end position="78"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="85"/>
<end position="89"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="100"/>
<end position="105"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="107"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="116"/>
<end position="119"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="124"/>
<end position="130"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="131"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="137"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="146"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="157"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="168"/>
<end position="176"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="179"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="186"/>
<end position="191"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3AY4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SGJ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3SGK"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21768335"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22023369"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23006327"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7700021"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8608639"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8609432"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8874200"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9242542"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9276722"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="254" mass="29089" checksum="D38D178D32C67337" modified="1990-08-01" version="2" precursor="true">MWQLLLPTALLLLVSAGMRTEDLPKAVVFLEPQWYRVLEKDSVTLKCQGAYSPEDNSTQWFHNESLISSQASSYFIDAATVDDSGEYRCQTNLSTLSDPVQLEVHIGWLLLQAPRWVFKEEDPIHLRCHSWKNTALHKVTYLQNGKGRKYFHHNSDFYIPKATLKDSGSYFCRGLFGSKNVSSETVNITITQGLAVSTISSFFPPGYQVSFCLVMVLLFAVDTGLYFSVKTNIRSSTRDWKDHKFKWRKDPQDK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

